Explore

Trendline Trendline
AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum

AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum

AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
Trendline Trendline
AN2 Therapeutics to Engage in 2026 Stifel Virtual Targeted Oncology Forum

AN2 Therapeutics to Engage in 2026 Stifel Virtual Targeted Oncology Forum

AN2 Therapeutics to Engage in 2026 Stifel Virtual Targeted Oncology Forum
Trendline Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Trendline Trendline
Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026

Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026

Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026
Trendline Trendline
Vir Biotechnology Reports Strong Financial Position and Advances in Cancer and Hepatitis Delta Programs

Vir Biotechnology Reports Strong Financial Position and Advances in Cancer and Hepatitis Delta Programs

Vir Biotechnology Reports Strong Financial Position and Advances in Cancer and Hepatitis Delta Programs
Trendline Trendline
TORL BioTherapeutics Appoints Aran Maree as CEO to Lead Next Growth Phase

TORL BioTherapeutics Appoints Aran Maree as CEO to Lead Next Growth Phase

TORL BioTherapeutics Appoints Aran Maree as CEO to Lead Next Growth Phase
Trendline Trendline
Verastem Oncology Reports Financial Results and Initiates New Cancer Trials

Verastem Oncology Reports Financial Results and Initiates New Cancer Trials

Verastem Oncology Reports Financial Results and Initiates New Cancer Trials
Trendline Trendline
Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors

Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors

Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors
Trendline Trendline
Generate Biomedicines Reports Q1 2026 Financial Results Amid Clinical Advancements

Generate Biomedicines Reports Q1 2026 Financial Results Amid Clinical Advancements

Generate Biomedicines Reports Q1 2026 Financial Results Amid Clinical Advancements
Trendline Trendline
Vir Biotechnology to Present at Bank of America Healthcare Conference

Vir Biotechnology to Present at Bank of America Healthcare Conference

Vir Biotechnology to Present at Bank of America Healthcare Conference
Trendline Trendline
Innate Pharma Schedules Q1 2026 Business Update Conference Call

Innate Pharma Schedules Q1 2026 Business Update Conference Call

Innate Pharma Schedules Q1 2026 Business Update Conference Call
Trendline Trendline
Merck Completes Acquisition of Terns Pharmaceuticals, Expanding Oncology Pipeline

Merck Completes Acquisition of Terns Pharmaceuticals, Expanding Oncology Pipeline

Merck Completes Acquisition of Terns Pharmaceuticals, Expanding Oncology Pipeline